AMERISOURCE HEALTH SERVICES — Montelukast Importer Profile
Pharmaceutical Importer · #1 buyer for Montelukast · $1.7M import value · 61 shipments · UNITED STATES · DGFT Verified
AMERISOURCE HEALTH SERVICES is the #1 importer of Montelukast from India with $1.7M in import value and 61 verified shipments. AMERISOURCE HEALTH SERVICES holds a 1.3% market share in Montelukast imports based in UNITED STATES. The company sources from 1 verified supplier across 35 formulations shipped to 2 countries. Overall, AMERISOURCE HEALTH SERVICES imports 8 pharmaceutical products worth $8.9M across 6 therapeutic categories.
AMERISOURCE HEALTH SERVICES — Montelukast Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Montelukast to AMERISOURCE HEALTH SERVICES?
Verified from 61 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MACLEODS PHARMACEUTICALS LIMITED | $1.7M | 61 | 100.0% |
AMERISOURCE HEALTH SERVICES sources Montelukast from 1 verified Indian supplier based on 61 customs records. The primary supplier is MACLEODS PHARMACEUTICALS LIMITED accounting for 100.0% of imports.
How Does AMERISOURCE HEALTH SERVICES Compare to Nearest Montelukast Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | DR. REDDYS LABORATORIES, INC | UNITED STATES | $2.3M | 46 | $50.0K |
| 9 | UNICHEM PHARMACEUTICALS (USA), INC | UNITED STATES | $2.3M | 45 | $50.0K |
| 1 | AMERISOURCE HEALTH SERVICES ★ | UNITED STATES | $2.2M | 44 | $50.0K |
| 2 | MACLEODS PHARMA USA ,INC | UNITED STATES | $2.0M | 41 | $50.0K |
| 12 | DR REDDYS LABORATORIES INC | UNITED STATES | $2.0M | 40 | $50.0K |
AMERISOURCE HEALTH SERVICES ranks #1 among 1,324 Montelukast importers from India. Average shipment value of $50.0K compared to the market average of $23.1K. The closest competitors by value are DR. REDDYS LABORATORIES, INC and UNICHEM PHARMACEUTICALS (USA), INC.
Where Does AMERISOURCE HEALTH SERVICES Import Montelukast To?
Destination countries from 61 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $1.6M | 55 | 93.6% |
| UNITED STATES OF AMERICA | $107.1K | 6 | 6.4% |
AMERISOURCE HEALTH SERVICES imports Montelukast to 2 countries. The primary destination is UNITED STATES receiving 93.6% of shipments worth $1.6M.
What Montelukast Formulations Does AMERISOURCE HEALTH SERVICES Import?
| Formulation | Value | Shipments |
|---|---|---|
| DRUG&PHAR.HARMLESS MED-MONTELUKAST SODIU | $167.8K | 5 |
| DRUG&PHAR.HARMLESS MED.-MONTELUKAST SODI | $156.0K | 4 |
| DRUG&PHA.HARMLES MED-MONTELUKAST SODIUM10MG TAB.-NDC NO.68001-0361-03B/N:BMC92364A/BMC92366B/BMC92365A**NOS | $141.6K | 3 |
| DRUGS&PHA.HARMLESS MED.MONTELUKAST SODIU | $105.8K | 4 |
| DRUG&PHA.HARMLES MED-MONTELUKAST SODIUM10MG TABLETS-NDC NO.68001-0361-03B/N:BMC92371A/BMC92372AM/D.DEC-23E/D.NOV-26NOS | $92.8K | 3 |
| DRUG&PHA.HARMLES MED-MONTELUKAST SODIUM10MG TABLETS-NDC NO.68001-0361-03,B/N.BMC92405C,BMC92403A,BMC92402A,BMC92404A** | $75.1K | 3 |
| DRUG&PHAR.HARMLESS MEDICINES-MONTELUKAST | $57.7K | 3 |
| DRUG&PHA.HARMLES MED.-MONTELUKAST SODIUM | $50.0K | 1 |
| MONTELUKAST SODIUM 10MG TABLETS - NDC NO.68001-0361-03 BN.BMC92355A MFG:10/23 EXP:09/26 | $50.0K | 1 |
| MONTELUKAST SODIUM 10MG TABLETS-NDC NO.NO.68001-0361-03, BATCH NO.BMC92355A,BMC92357A,BMC92356A,M.DT.10/23,E.DT.9/26, | $50.0K | 1 |
AMERISOURCE HEALTH SERVICES imports 35 distinct Montelukast formulations from India. The top formulation is DRUG&PHAR.HARMLESS MED-MONTELUKAST SODIU with 5 shipments worth $167.8K.
Regulatory Requirements: Importing Montelukast into United States
What AMERISOURCE HEALTH SERVICES and other importers must comply with to import Montelukast from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Montelukast
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Montelukast from India and How Much Does AMERISOURCE HEALTH SERVICES Import?
India exported $30.6M worth of Montelukast through 6,431 shipments from 510 suppliers to 138 countries, serving 1,324 buyers globally. AMERISOURCE HEALTH SERVICES imports $1.7M of this total, accounting for 1.3% of India's Montelukast exports with 61 shipments from UNITED STATES. This is verified from 61 customs shipment records covering 35 distinct formulations.
What Is the Average Order Value for AMERISOURCE HEALTH SERVICES's Montelukast Imports?
AMERISOURCE HEALTH SERVICES's average Montelukast order value is $27.4K per consignment, based on 61 shipments totaling $1.7M. AMERISOURCE HEALTH SERVICES is based in UNITED STATES and ranks #1 among all Montelukast importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Montelukast to AMERISOURCE HEALTH SERVICES?
AMERISOURCE HEALTH SERVICES sources Montelukast from 1 verified Indian supplier: MACLEODS PHARMACEUTICALS LIMITED ($1.7M, 100.0%). This is based on 61 customs records.
How Does AMERISOURCE HEALTH SERVICES Compare to Other Montelukast Importers?
AMERISOURCE HEALTH SERVICES ranks #1 among 1,324 Montelukast importers from India with a 1.3% market share. The top 3 importers are UNICHEM PHARMACEUTICALS (USA) INC. ($5.6M), BREATHEFREE LANKA PVT LTD ($3.4M), UNICHEM PHARMACEUTICALS USA INC ($2.6M). AMERISOURCE HEALTH SERVICES processed 61 shipments from UNITED STATES.
About AMERISOURCE HEALTH SERVICES
AMERISOURCE HEALTH SERVICES imports 8 products worth $8.9M. Beyond Montelukast, top products include Carvedilol, Fluconazole, Glimepiride, Etoposide, Anastrozole. View the complete AMERISOURCE HEALTH SERVICES profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Montelukast — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Montelukast shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: AMERISOURCE HEALTH SERVICES matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as AMERISOURCE HEALTH SERVICES's capped import value divided by total capped export value for Montelukast across all Indian exporters.
- 5.Verified Records: This page is backed by 61 individual customs records matching AMERISOURCE HEALTH SERVICES importing Montelukast, covering 35 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 138+ countries, 1,324+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Montelukast Import Data for AMERISOURCE HEALTH SERVICES
Access order-level details, pricing data, supplier connections, and competitive analysis for AMERISOURCE HEALTH SERVICES's Montelukast imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
AMERISOURCE HEALTH SERVICES
Full Company Profile →
8 products · $8.9M total trade · 6 categories
AMERISOURCE HEALTH SERVICES × Montelukast
Verified from customs records
Company Overview
Top Products by AMERISOURCE HEALTH SERVICES
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for AMERISOURCE HEALTH SERVICES.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Montelukast. For current order-level data, contact TransData Nexus.